By Rishab Shaju and Ateev Bhandari (Reuters) -Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

Shares of Heartflow opened at $28 on Friday, jumping over 47% above the initial public offering price of $19 per share in their Nasdaq debut. This opening price valued the medical technology company ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized ...

Heartflow (NASDAQ: HTFL) stock surges ~50% as the company focused on AI-driven tools for the diagnosis of heart diseases make ...

Heartflow announced today that it closed its upsized initial public offering (IPO) with proceeds totaling approximately $364.2 million.

The stock of medical imaging and diagnostics software company Heartflow jumped 50% in its market debut on Aug. 8; the latest ...

Medical imaging company Heartflow rose nearly 50% on its first day, joining Firefly, Figma, and Circle as big IPO gainers.

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

(Reuters) -Heartflow shares surged 47.4% in their Nasdaq debut on Friday, giving the medtech firm a valuation of $2.27 billion, as the IPO market gathers momentum and outrides tariff worries. The ...

Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO market gathers momentum and outrides tariff worries. The shares opened at ...